BioPharma Credit PLC Cash Flow Reinvestment Rate
BioPharma Credit PLC cash flow reinvestment rate. BioPharma Credit PLC (BPCR) has a Cash Flow Reinvestment Rate of 0.00x as of June 2025, reinvesting $0.00 (capex $0.00 ) from operating cash flow of $33.76 Million. Explore BPCR operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of BioPharma Credit PLC (2017–2024)
Cash flow reinvestment rate of BioPharma Credit PLC from 2017 to 2024. Historical reinvestment intensity for BioPharma Credit PLC across 8 annual periods. Also explore BPCR year-over-year net asset growth to track the company's year-over-year net asset growth rate.
BioPharma Credit PLC Cash Flow Reinvestment Rate by Year (2017–2024)
BioPharma Credit PLC cash flow reinvestment rate by year from 2017 to 2024. Year-by-year capital reinvestment analysis for BioPharma Credit PLC. For the full cash flow conversion analysis, see BioPharma Credit PLC operating cash flow efficiency.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.35x | $39.07 Million | $111.91 Million | $0.00 | ▲ +2497.0% |
| 2023 | 0.01x | $1.66 Million | $123.18 Million | $0.00 | ▼ -94.9% |
| 2022 | 0.26x | $48.19 Million | $184.28 Million | $0.00 | ▼ -73.4% |
| 2021 | 0.98x | $94.82 Million | $96.44 Million | $0.00 | ▲ +20.3% |
| 2020 | 0.82x | $47.47 Million | $58.07 Million | $0.00 | ▲ +7.2% |
| 2019 | 0.76x | $100.30 Million | $131.52 Million | $0.00 | ▼ -88.3% |
| 2018 | 6.51x | $436.99 Million | $67.14 Million | $0.00 | ▼ -57.7% |
| 2017 | 15.38x | $354.74 Million | $23.07 Million | $0.00 | — |